Resharing now that the full article is out! Updated NMDP/CIBMTR guidelines on donor selection for allo-HCT. Grateful to have contributed to this effort 🧵
https://t.co/b1RyyLQf6u
US nonprofit hospitals spent $7.8 billion on management consultants from 2009 to 2023, but contracts were not associated with meaningful changes in finance, operations, or quality of care. 🧵
https://t.co/QQswMYxrG8
@nihardesai89@Haemophage@GonzaloBentoli1@KFHemeOnc@sghmd 7/8 MMUD if using PTCy and no DSA. Some data suggest younger MMUDs may outperform “older” haplos in this setting. CMV/ABO/sex are a wash, so the main differentiator: 24 vs 35. Still, 35 is young, so both are 👍 options. Tie-breakers: urgency, expertise, graft, and trial options.